| Application no. and date | 10177951.0 (espacenet) (Federated) (European Patent Register), 20050314 | | Patent/reg. no. and date | DK/EP 2295056, 20160106 | | Publication date | 20110316 | | Priority no. and date | US 553578 P, 20040315 | | EP pub. no. and date |
EP 2295056 20110316 | | Effective date | | | Applicant/owner | Sumitomo Pharma Co., Ltd., 6-8, Doshomachi 2-chome,
Chuo-ku, Osaka-shi
Osaka 541-0045, JP,
Sunesis Pharmaceuticals, Inc., 395 Oyster Point Blvd., Suite 400
South San Francisco, CA 94080, US | | Applicant ref. no. | P81008647DK01E | | Inventor | ADELMAN, Daniel, C., 23 Woodleaf Avenue
Redwood City, CA 94061, US,
SILVERMAN, Jeffrey A., 1416 Columbus Avenue
Burlingame, CA 94010, US,
MASARU, Higaki, c/o Sumitomo Dainippon Pharma Co., Ltd.
6-8, Dosho-machi 2-chome
Chuo-ku
Osaka-shi, Osaka 541-8524, JP,
SATOSHI, Nakao, c/o Sumitomo Dainippon Pharma Co., Ltd.
6-8, Dosho-machi 2-chome
Chuo-ku
Osaka-shi
Osaka-shi, Osaka 541-8524, JP | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/4375 (2006.01) , A61K 31/44 (2006.01) , A61K 31/4745 (2006.01) , A61K 31/555 (2006.01) , A61K 31/7068 (2006.01) , A61K 38/18 (2006.01) , A61K 41/00 (2006.01) , A61K 45/06 (2006.01) , A61K 47/12 (2006.01) , A61K 9/00 (2006.01) , A61P 35/00 (2006.01) , A61P 35/02 (2006.01) , C07D 471/04 (2006.01) | | Title | Anvendelse af SNS-595 til behandling af leukæmi | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
